Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM

Hodgkin Lymphoma ◽

Long Term Results ◽

High Dose ◽

Ibritumomab Tiuxetan ◽

Hematopoietic Stem ◽

Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12610 ◽

2017 ◽

Vol 13 (5) ◽

pp. e423-e429 ◽

Cited By ~ 8

Author(s):

Youwu Shi ◽

Peng Liu ◽

Shengyu Zhou ◽

Jianliang Yang ◽

Xiaohong Han ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Hematopoietic Stem ◽

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma

10.1016/j.bbmt.2004.11.017 ◽

2005 ◽

Vol 11 (2) ◽

pp. 129-135 ◽

Cited By ~ 21

Author(s):

Noel Laudi ◽

Mukta Arora ◽

Linda J. Burns ◽

Jeffrey S. Miller ◽

Philip B. McGlave ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Low Grade ◽

Hematopoietic Stem ◽

Non Hodgkin Lymphoma ◽

Long Term Follow Up

High-Dose Therapy/Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Marginal Zone Non-Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.03.011 ◽

2011 ◽

Vol 11 (3) ◽

pp. 253-256 ◽

Cited By ~ 12

Author(s):

Lanfang Li ◽

Philip Bierman ◽

Julie Vose ◽

Fausto Loberiza ◽

James O. Armitage ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Marginal Zone ◽

High Dose ◽

High Dose Therapy ◽

Hematopoietic Stem ◽

High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients?

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2015.07.001 ◽

2015 ◽

Vol 6 (5) ◽

pp. 344-345 ◽

Cited By ~ 1

Author(s):

Tanya M. Wildes ◽

Amanda Cashen

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

High Dose ◽

High Dose Therapy ◽

Hematopoietic Stem ◽

Follicular non-Hodgkin lymphoma: long-term results of stem-cell transplantation

Current Opinion in Oncology ◽

10.1097/cco.0b013e32830b61ac ◽

2008 ◽

Vol 20 (5) ◽

pp. 502-508 ◽

Cited By ~ 10

Author(s):

Paul M Barr ◽

Hillard M Lazarus

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Long Term Results ◽

Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement

Leukemia & Lymphoma ◽

10.1080/10428190903156745 ◽

2009 ◽

Vol 50 (9) ◽

pp. 1488-1493 ◽

Cited By ~ 10

Author(s):

Heng-Xiang Wang ◽

Hong-Min Yan ◽

Jing Liu ◽

Lian-Ning Duan ◽

Zhi-Dong Wang ◽

...

Keyword(s):

Bone Marrow ◽

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Bone Marrow Involvement ◽

Hematopoietic Stem ◽

Results of 10-Year Single Center Experience with Pharmacokinetics Directed Intravenous Busulfan, Cyclophosphamide and Etoposide Preparative Regimen in Autologous Hematopoietic Stem Cell Transplantation for Intermediate and High Grade Non-Hodgkin Lymphoma

10.1016/j.bbmt.2013.12.260 ◽

2014 ◽

Vol 20 (2) ◽

pp. S162-S163

Author(s):

Neha R. Patil ◽

Donna Salzman ◽

William Donnellan ◽

William Vaughan

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

High Grade ◽

Single Center ◽

Hematopoietic Stem ◽

Single Center Experience ◽

Non Hodgkin Lymphoma ◽

Preparative Regimen

The Additional Use of Viral Entry Inhibitors during Autologous Hematopoietic Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma and HIV-1 Infection

10.1016/j.bbmt.2009.10.030 ◽

2011 ◽

Vol 17 (4) ◽

pp. 586-587 ◽

Cited By ~ 6

Author(s):

Gero Hütter ◽

Kristina Allers ◽

Thomas Schneider

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Viral Entry ◽

Hematopoietic Stem ◽

Entry Inhibitors ◽

Non Hodgkin Lymphoma ◽

Hiv 1

Feasibility of and Decreased Inpatient Hospital Days for Non-Hodgkin Lymphoma (NHL) and Hodgkin Lymphoma (HL) Patients with Outpatient BEAM Using Daily Etoposide and Cytarabine and Autologous Hematopoietic Stem Cell Transplantation (AHCT)

10.1016/j.bbmt.2019.12.712 ◽

2020 ◽

Vol 26 (3) ◽

pp. S159

Author(s):

Kathleen Cavalier ◽

Naomi Cazeau ◽

Valkal Bhatt ◽

Courtney McElrath ◽

Nicole J. LeStrange ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Hematopoietic Stem ◽

Inpatient Hospital ◽

Non Hodgkin Lymphoma ◽

Hospital Days

Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.03.023 ◽

2019 ◽

Vol 19 (6) ◽

pp. 345-355.e7

Author(s):

Young-Woo Jeon ◽

Seugyun Yoon ◽

Gi June Min ◽

Sung-Soo Park ◽

Silvia Park ◽

...

Keyword(s):

Stem Cell ◽

Hodgkin Lymphoma ◽

Clinical Outcomes ◽

Total Body Irradiation ◽

Conditioning Regimen ◽

Hematopoietic Stem ◽

Non Hodgkin Lymphoma ◽

Total Body